A significant number of studies reported that the dysregulation of cGMP/PKG signaling pathway accounts for numerous pathologies, including vascular and ventricular dysfunction, fibrosis, neurodegenerative disorders, hypertrophy and cancer [16,17,18,19]. This evidence concerns the gene PRKG1 and cancer.